Mirae Asset Global ETFs Holdings’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-1,143
Closed -$30K – 3236
2026
Q1
$30K Sell
1,143
-200
-15% -$25.1K ﹤0.01% 2997
2025
Q4
$334K Buy
1,343
+252
+23% +$57.5K ﹤0.01% 2102
2025
Q3
$230K Sell
1,091
-208
-16% -$36.7K ﹤0.01% 2255
2025
Q2
$128K Buy
+1,299
New +$113K ﹤0.01% 2484

Other funds holding GOSS

Mirae Asset Global ETFs Holdings's GOSS Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Gossamer Bio (GOSS) in Q2 2026, closing a stake of 1,143 shares — an estimated $30K sold.

Mirae Asset Global ETFs Holdings first reported a position in GOSS in Q2 2025 and held it in 4 quarters. The position peaked at $334K in Q4 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Gossamer Bio position as of Q2 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 1,143 Gossamer Bio shares in Q2 2026, an estimated $30K.
  • Mirae Asset Global ETFs Holdings first reported a position in Gossamer Bio in Q2 2025 and held it in 4 quarters.
  • Mirae Asset Global ETFs Holdings's Gossamer Bio position peaked at $334K in Q4 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.